The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Elevated factor VIII levels and risk of venous thrombosis
Abstract
Summary: Modern thrombophilia testing fails to identify any underlying prothrombotic tendency in a significant number of patients presenting with objectively confirmed venous thromboemboembolism (VTE). This observation has led to a search for other novel inherited or acquired human thrombophilias. Although a number of putative mechanisms have been described, the evidence behind many of these candidates remains weak. In contrast, an increasing body of work supports the hypothesis that increased plasma factor VIII (FVIII) levels may be important in this context. An association between elevated plasma FVIII levels and VTE was first described in the Leiden Thrombophilia Study (LETS). Subsequently, these conclusions have been supported by an increasing number of independent case–control studies. Cumulatively, these studies have clearly demonstrated that high FVIII levels constitute a prevalent, dose‐dependent risk factor for VTE. Furthermore, more recent studies have shown that the risk of recurrent venous thrombosis is also significantly increased in patients with high FVIII levels. In this review, we present the evidence supporting the hypothesis that elevated FVIII levels constitute a clinically important thrombophilia. In addition, we examine the biological mechanisms that may underlie persistently elevated FVIII levels, and the pathways through which high FVIII may serve to increase thrombotic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131 · cited 3×
“Elevated FVIII levels and venous thrombosis The Leiden Thrombophilia Study (LETS) was the first to report an association between high plasma levels of FVIII and VTE (Koster et al, 1995).”
BackgroundThe effect of ABO blood group on the diagnosis of von Willebrand disease
Gill, J., Endres-Brooks, J., Bauer, P., Marks, W. J., & Montgomery, R. (1987) · Blood · doi:10.1182/blood.v69.6.1691.1691 · Cited by 957
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763 · cited 3×
“The hypothesis that high plasma FVIII:C levels influence risk of recurrent VTE was further addressed in the larger prospective Austrian Study on Recurrent VTE (Kyrle et al, 2000).”
BackgroundResultHigh Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
Meijers, J. C. M., Tekelenburg, W. L. H., Bouma, B. N., Bertina, R. M., & Rosendaal, F. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421004 · Cited by 700
Clinical guidelines for testing for heritable thrombophilia
Baglin, T., Gray, E., Greaves, M., Hunt, B. J., Keeling, D., Machin, S., Mackie, I., Makris, M., Nokes, T., Perry, D., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08022.x · Cited by 499
High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism
in 't Anker, P., Koopman, M., Reitsma, P., Prins, M., van den Ende, A., Büller, H., & Kraaijenhagen, R. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613747 · Cited by 489
Conlan, M. G., Folsom, A. R., Finch, A., Davis, C. E., Sorlie, P., Marcucci, G., Wu, K. K., & For the ARIC Study Investigators (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649589 · Cited by 439
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins, P. V., & O’Donnell, J. S. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00975.x · Cited by 431
Self-citationSmith, N. L., Chen, M.-H., Dehghan, A., Strachan, D. P., Basu, S., Soranzo, N., Hayward, C., Rudan, I., Sabater-Lleal, M., Bis, J. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.869156 · Cited by 370
Advances in understanding pathogenic mechanisms of thrombophilic disorders
Dahlbäck, B. (2008) · Blood · doi:10.1182/blood-2008-01-077909 · Cited by 345
Elevated Factor VIII Levels and the Risk of Thrombosis
Kamphuisen, P. W., Eikenboom, J. C. J., & Bertina, R. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.731 · Cited by 316
British Committee for Standards in Haematology
Chaffe, B., Elliott, C., Howell, C., Jones, J., Murray, S. R., Norfolk, D., Pirie, L., & Russell, J. K. (2012) · Cited by 311
Gallinaro, L., Cattini, M. G., Sztukowska, M., Padrini, R., Sartorello, F., Pontara, E., Bertomoro, A., Daidone, V., Pagnan, A., & Casonato, A. (2008) · Blood · doi:10.1182/blood-2007-11-122945 · Cited by 298
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/1vqg-s718 · Cited by 266
Kamphuisen, P., Eikenboom, J., Vos, H., Pablo, R., Sturk, A., Rosendaal, F., & Bertina, R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614553 · Cited by 259
Genetic Determinants of Hemostasis Phenotypes in Spanish Families
Souto, J. C., Almasy, L., Borrell, M., Garí, M., Martínez, E., Mateo, J., Stone, W. H., Blangero, J., & Fontcuberta, J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1546 · Cited by 249
Goldenberg, N. A., Knapp-Clevenger, R., & Manco-Johnson, M. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040161 · Cited by 237
Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism
Saenko, E. L., Yakhyaev, A. V., Mikhailenko, I., Strickland, D. K., & Sarafanov, A. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37685 · Cited by 229
O’Donnell, J., Tuddenham, E. G. D., Manning, R., Kemball-Cook, G., Johnson, D., & Laffan, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656061 · Cited by 228
Self-citationLenting, P. J., Neels, J. G., van den Berg, B. M. M., Clijsters, P. P. F. M., Meijerman, D. W. E., Pannekoek, H., van Mourik, J. A., Mertens, K., & van Zonneveld, A.-J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23734 · Cited by 219
Mumford, A., Manning, R., Laffan, M., & O’Donnell, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613748 · Cited by 208
Self-citationFactor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
TERRAUBE, V., O’DONNELL, J. S., & JENKINS, P. V. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02005.x · Cited by 176
Self-citationBank, I., Libourel, E. J., Middeldorp, S., Hamulyák, K., Van Pampus, E. C. M., Koopman, M. M. W., Prins, M. H., Van Der Meer, J., & Büller, H. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01033.x · Cited by 176
Vormittag, R., Simanek, R., Ay, C., Dunkler, D., Quehenberger, P., Marosi, C., Zielinski, C. C., & Pabinger, I. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.190827 · Cited by 151
Bovenschen, N., Herz, J., Grimbergen, J. M., Lenting, P. J., Havekes, L. M., Mertens, K., & van Vlijmen, B. J. M. (2003) · Blood · doi:10.1182/blood-2002-07-2081 · Cited by 135
Factor VIII and von Willebrand Factor
Vlot, A. J., Koppelman, S., Bouma, B. N., & Sixma, J. J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614927 · Cited by 125
O’Donnell, J., Boulton, F. E., Manning, R. A., & Laffan, M. A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.103997 · Cited by 125
Self-citationFamilial Clustering of Factor VIII and von Willebrand Factor Levels
Houwing‐Duistermaat, J. J., van Houwelingen, H. C., Eikenboom, J. C. J., Bertina, R. M., Rosendaal, F. R., & Kamphuisen, P. W. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614985 · Cited by 123
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism
Cristina, L., Cosmi, B., Cini, M., Frascaro, M., Guazzaloca, G., & Palareti, G. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04795.x · Cited by 118
Smith, N. L., Rice, K. M., Bovill, E. G., Cushman, M., Bis, J. C., McKnight, B., Lumley, T., Glazer, N. L., Vlieg, A. V. H., Tang, W., et al. (2010) · Blood · doi:10.1182/blood-2010-10-315473 · Cited by 116
Nossent, A. Y., MARION, V. V., van Tilburg, N. H., Rosendaal, F. R., Bertina, R. M., van MOURIK, J. A., & Eikenboom, J. C. J. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02273.x · Cited by 105
Machlus, K. R., Colby, E., Wu, J. R., Koch, G. G., Key, N. S., & Wolberg, A. S. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0180 · Cited by 103
Kamphuisen, P. W., Eikenboom, J. C. J., Rosendaal, F. R., Koster, T., Blann, A. D., Vos, H. L., & Bertina, R. M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03089.x · Cited by 94
Kinetics of factor VIII-von Willebrand factor association
Vlot, A., Koppelman, S. J., Meijers, J. C. M., Dama, C., van den Berg, H. M., Bouma, B. N., Sixma, J. J., & Willems, G. M. (1996) · Blood · doi:10.1182/blood.v87.5.1809.1809 · Cited by 88
Miller, C. H., Dilley, A., Richardson, L. C., Hooper, W. C., & Evatt, B. L. (2001) · American Journal of Hematology · doi:10.1002/ajh.1090 · Cited by 88
McGrath, R. T., McKinnon, T. A. J., Byrne, B. J., O’Kennedy, R. J., Terraube, V., McRae, E., Preston, R. J. S., Laffan, M., & O’Donnell, J. S. (2009) · Blood · doi:10.1182/blood-2009-09-241547 · Cited by 87
Self-citationA New Animal Model of Thrombophilia Confirms that High Plasma Factor VIII Levels Are Thrombogenic
Kawasaki, T., Kaida, T., Arnout, J., Vermylen, J., & Hoylaerts, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614471 · Cited by 83
The rise in clotting factor VIII induced in man by adrenaline: effect of α‐ and β‐blockers
Ingram, G. I. C., & Jones, R. V. (1966) · The Journal of Physiology · doi:10.1113/jphysiol.1966.sp008102 · Cited by 80
Mansvelt, E. P. G., Laffan, M., McVey, J. H., & Tuddenham, E. G. D. (1998) · PubMed · Cited by 77
Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels
Antoni, G., Oudot‐Mellakh, T., Dimitromanolakis, A., Germain, M., Cohen, W., Wells, P. S., Lathrop, M. G., Gagnon, F., Morange, P., & Trégouët, D. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-102 · Cited by 77
Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia
Kamphuisen, P. W., Lensen, R., Houwing‐Duistermaat, J. J., Eikenboom, J. C. J., Harvey, M., Bertina, R. M., & Rosendaal, F. R. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02091.x · Cited by 76
Kreuz, W., Stoll, M., Junker, R., Heinecke, A., Schobeß, R., Kurnik, K., Kelsch, R., & Nowak‐Göttl, U. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000227510.36653.ed · Cited by 73
Risk factors for venous thrombosis in the black population
Patel, R. K. P., Ford, E., Thumpston, J., & Arya, R. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-05-0311 · Cited by 69
Familial Clustering of High Factor VIII Levels in Patients With Venous Thromboembolism
Schambeck, C. M., Hinney, K., Haubitz, I., Taleghani, B. M., Wahler, D., & Keller, F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.2.289 · Cited by 69
Venous Thrombosis, Oral Contraceptives and High Factor VIII Levels
Bloemenkamp, K. W. M., Helmerhorst, F., Vandenbroucke, J. P., & Rosendaal, F. R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614323 · Cited by 68
Kamphuisen, P. W., Rosendaal, F. R., Eikenboom, J. C. J., Bos, R., & Bertina, R. M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1382 · Cited by 67
Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism
O’Donnell, J. S., Mumford, A. D., Manning, R. A., & Laffan, M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03146.x · Cited by 65
Self-citationVormittag, R., Bencúr, P., Ay, C., Tengler, T., Vukovich, T., Quehenberger, P., Mannhalter, C., & Pabinger, I. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02337.x · Cited by 62
High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII
Großmann, R., Zonnur, S., Berger, M., Teuchert, K., SPAHN, A., Walter, U., & Schambeck, C. M. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0063 · Cited by 52
The disappearing act of factor VIII
Lenting, P. J., Christophe, O. D., & Guéguen, P. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01864.x · Cited by 51
Machlus, K. R., Lin, F., & Wolberg, A. S. (2011) · Blood · doi:10.1182/blood-2011-06-362814 · Cited by 50
6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII
for the AUREC-FVIII investigators (as listed in acknowledgements), Eischer, L., Gartner, V., Schulman, S., Kyrle, P. A., & Eichinger, S. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0626-1 · Cited by 47
High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden
Lensen, R., Bertina, R. M., Vandenbroucke, J. P., & Rosendaal, F. R. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02946.x · Cited by 43
Tichelaar, V., Mulder, A. B., Kluin‐Nelemans, H. C., & Meijer, K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.09.024 · Cited by 41
Oger, E., Lacut, K., Dreden, P. V., Bressollette, L., Abgrall, J., Blouch, M., Scarabin, P., & Mottier, D. (2003) · PubMed · Cited by 39
Hoppener, M. R., Kraaijenhagen, R. A., Hutten, B. A., Buller, H. R., Peters, R. J. G., & Levi, M. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00851.x · Cited by 34
High Plasma Level of Factor VIII - An Important Risk Factor for Venous Thromboembolism -
Ota, S., Yamada, N., Ogihara, Y., Tsuji, A., Ishikura, K., Nakamura, M., Wada, H., & Ito, M. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1051 · Cited by 34
Ryland, J., Lawrie, A. S., Mackie, I. J., & Machin, S. J. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.020 · Cited by 32
Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
Legnani, C., Cini, M., Cosmi, B., Poggi, M., Boggian, O., & Palareti, G. (2004) · PubMed · Cited by 31
Cunningham, N., Laffan, M., Manning, R. A., & O’Donnell, J. S. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000178831.45049.aa · Cited by 31
Self-citationMitrio, V. D., Marino, R., Scaraggi, F. A., Bari, L. D., Giannoccaro, F., Petronelli, M., Ranieri, P., Tannoia, N., & Schiraldi, O. (1999) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199910000-00002 · Cited by 23
Roelse, J., Koopman, M. M. W., Buller, H. R., ten Cate, J. W., Montaruli, B., van MOURIK, J. A., & Voorberg, J. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.349885.x · Cited by 23
Nossent, A. Y., DAI, L., Rosendaal, F. R., Vos, H. L., & Eikenboom, J. C. J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01109.x · Cited by 17
Bowen, D. J., Maclean, R., Pellard, S., & Collins, P. W. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02830.x · Cited by 15
Passamonti, S. M., Bucciarelli, P., Bader, R., & Martinelli, I. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.017 · Cited by 15
O’Donnell, J. S., Manning, R. A., & Laffan, M. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04571.x · Cited by 8
Self-citationNossent, A. Y., Vos, H. L., Rosendaal, F. R., Bertina, R. M., & Eikenboom, J. C. J. (2008) · Haematologica · doi:10.3324/haematol.12296 · Cited by 4
Cited by
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O’Sullivan, J. M., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15490 · Cited by 337
Self-citationThe physiological functions of iron regulatory proteins in iron homeostasis - an update
Zhang, D.-L., Ghosh, M. C., & Rouault, T. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00124 · Cited by 301
Rietveld, I. M., Lijfering, W. M., le Cessie, S., Bos, M. H. A., Rosendaal, F. R., Reitsma, P. H., & Cannegieter, S. C. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14343 · Cited by 154
Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
Chen, C.-Y., Tran, D. M., Cavedon, A., Cai, X., Rajendran, R., Lyle, M. J., Martini, P. G. V., & Miao, C. H. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.015 · Cited by 89
Metadata
- Authors
- Jenkins, P. V., Rawley, O., Smith, O. P., & O'Donnell, J. S.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2012-04-25
- Volume
- 157
- Issue
- 6
- Pages
- 653-663
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2071507649
- Cited by
- 285
- References
- 69
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.